Chronic Kidney Disease News

Healio has compiled a list of its most-read health equity news in 2023.

Healio has compiled a list of its most-read chronic kidney disease care news in 2023.

The FDA has granted full approval for Tarpeyo delayed-release capsules to reduce the loss of kidney function in adults with IgA nephropathy who are at risk for disease progression, according to a press release.

Adults with pregnancy-related end-stage kidney disease have reduced access to transplant and nephrology care, which may worsen racial gaps for Black patients with this condition, according to a study.

Mycophenolate mofetil may be a viable alternative to steroids for induction therapy in children with steroid-sensitive idiopathic nephrotic syndrome, researchers found in a study.

The use of finenerone to reduce albuminuria in patients with chronic kidney disease and type 2 diabetes provided kidney and cardiovascular benefits when the urine albumin-to-creatine ratio was reduced by 30% or more, a study shows.

PHILADELPHIA — County-level structural racism may be a statistically significant predictor of death among people with kidney failure, according to research presented at ASN Kidney Week.

Using more stringent algorithms to define chronic kidney disease stage G4 may lead to lower estimates of disease incidence and a higher risk of kidney failure, researchers found.

Treatment of glomerular disease has a hard endpoint, Brad H. Rovin, MD, FACP, FASN, said — slowing progression of chronic kidney disease by stabilizing or improving eGFR.

Elevated resting heart rate may be a novel risk factor for end-stage renal disease, independent from other traditional risk factors, according to a study published in the Journal of the American Heart Association.